Search clinical trials for: Evaluation of safety/tolerability: COM902 in combination with COM701 (both at the RDFE)
Total 10 results
-
Compugen LtdRecruitingMultiple Myeloma | Ovarian Cancer | Lung Cancer | Advanced Cancer | Colon Cancer | Plasma Cell Neoplasm | HNSCC | Microsatellite Stable Colorectal Carcinoma | MSS-CRCUnited States
-
Compugen LtdBristol-Myers SquibbActive, not recruitingHead and Neck Cancer | Ovarian Cancer | Solid Tumor | Endometrial NeoplasmsUnited States
-
Centre Hospitalier Universitaire, AmiensUnknown
-
Centre Hospitalier Universitaire DijonRecruiting
-
Cancer Hospital of Guangxi Medical UniversityActive, not recruitingTACE | Lenvatinib | Tislelizumab | Advanced Unresectable Hepatocellular CarcinomaChina
-
Jagiellonian UniversityRecruitingSubclinical hypothyroïdism | PCOS (Polycystic Ovary Syndrome) of Bilateral Ovaries | Hypothalamic-Pituitary-Gonadal Axis DysfunctionPoland
-
Memorial Sloan Kettering Cancer CenterBoehringer Ingelheim; National Comprehensive Cancer NetworkCompletedHead and Neck Cancer | Squamous Cell CancerUnited States
-
Memorial Sloan Kettering Cancer CenterPfizer; Dana-Farber Cancer Institute; University of Pittsburgh; University of VirginiaCompletedNeurofibromatosis | Meningioma | CNS Cancer | Hemangioblastoma | Intracranial HemangiopericytomaUnited States
-
Gilead SciencesCompletedHepatitis CUnited States, Puerto Rico
-
Memorial Sloan Kettering Cancer CenterGlaxoSmithKline; University of WashingtonCompletedProstate Cancer | Castration-resistant, MetastaticUnited States